Ismaeil Haririan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ismaeil Haririan has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Farhad Rezaee
Department of Gastroenterology and Hepatology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands
1 shared publication- Fatemeh Amirzadeh-Ghasemi
Tarbiat Modares University
1 shared publication Kobra Rostamizadeh
Department of Pharmaceutical Biomaterials, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran
1 shared publicationMaryam Hassani
Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationMazda Rad-Malekshahi
Department of Pharmaceutical Biomaterials, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
1 shared publicationMojtaba Kamankesh
Department of Polymer Chemistry, School of Chemistry, College of Science, University of Tehran, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 30 October 2025
- Published by Springer Nature in Research Square
Electrospun Chitosan/PVA/CNT Nanofiber Composite for Sustained Fluconazole Delivery Against Biofilm-Forming Candida albicans
Innovative drug delivery methods are needed to improve efficacy due to the global increase in antifungal resistance, especially in Candida albicans . this study introduces a novel electrospun nanofiber platform containing fluconazole in a Chitosan-PVA-CNT-COOH matrix.A 50/50 chitosan/PVA blend with 0.25% CNT-COOH was used to electrospin nanofibers loaded with fluconazole at 10, 25, and 40 µg/mL. SEM and FT-IR were used to analyze the composition and morphology and stability was examined for 24 hours at 37°C in PBS. The pour plate method was used to evaluate the antifungal activity against Candida albicans , the MTT assay was performed for biofilm inhibition formation and cytotoxicity (on SW480 cell line) evaluation.Chitosan, PVA, CNT-COOH, and fluconazole were confirmed by FT-IR, and the nanofibers displayed consistent 70–80 nm diameters and retained their integrity after PBS. With SW480 viability exceeding 90% in comparison to free fluconazole, they demonstrated minimal cytotoxicity, completely inhibited C. albicans growth, and significantly decreased biofilms (p < 0.05).Chitosan system enhances fluconazole delivery, targets C. albicans , reduces toxicity, promising for reducing resistance.
- 30 October 2025
- Published by Springer Nature in Research Square
Open AccessElectrospun Chitosan/PVA/CNT Nanofiber Composite for Sustained Fluconazole Delivery Against Biofilm-Forming Candida albicans
Innovative drug delivery methods are needed to improve efficacy due to the global increase in antifungal resistance, especially in Candida albicans . this study introduces a novel electrospun nanofiber platform containing fluconazole in a Chitosan-PVA-CNT-COOH matrix.A 50/50 chitosan/PVA blend with 0.25% CNT-COOH was used to electrospin nanofibers loaded with fluconazole at 10, 25, and 40 µg/mL. SEM and FT-IR were used to analyze the composition and morphology and stability was examined for 24 hours at 37°C in PBS. The pour plate method was used to evaluate the antifungal activity against Candida albicans , the MTT assay was performed for biofilm inhibition formation and cytotoxicity (on SW480 cell line) evaluation.Chitosan, PVA, CNT-COOH, and fluconazole were confirmed by FT-IR, and the nanofibers displayed consistent 70–80 nm diameters and retained their integrity after PBS. With SW480 viability exceeding 90% in comparison to free fluconazole, they demonstrated minimal cytotoxicity, completely inhibited C. albicans growth, and significantly decreased biofilms (p < 0.05).Chitosan system enhances fluconazole delivery, targets C. albicans , reduces toxicity, promising for reducing resistance.